Detalles de la búsqueda
1.
Life expectancy and death pattern associated with systemic lupus erythematosus diagnosis in Brazil between 2000 and 2019.
Lupus
; 33(5): 536-542, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38414428
2.
Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America: Data From Argentina, Mexico, and Brazil.
J Clin Rheumatol
; 30(1): e9-e17, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37936271
3.
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.
Ann Rheum Dis
; 81(7): 970-978, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172961
4.
Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.
Clin Exp Rheumatol
; 40(7): 1258-1266, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34251312
5.
Transverse Myelitis in Systemic Lupus Erythematosus: Clinical Features and Prognostic Factors in a Large Cohort of Latin American Patients.
J Clin Rheumatol
; 27(6S): S204-S211, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32028309
6.
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).
Ann Rheum Dis
; 77(11): 1549-1557, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30045853
7.
COVID-19 in patients with rheumatic diseases: what is the real mortality risk?
Ann Rheum Dis
; 81(8): e134, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32660978
8.
The relevance of performing exercise test before starting supervised physical exercise in asymptomatic cardiovascular patients with rheumatic diseases.
Rheumatology (Oxford)
; 55(11): 1978-1986, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27481271
9.
II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment.
Adv Rheumatol
; 64(1): 48, 2024 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38890752
10.
Position statement of the Brazilian society of Rheumatology on mesna use as a preventive therapy for bladder disease in patients with systemic autoimmune diseases and systemic vasculitis under cyclophosphamide treatment.
Adv Rheumatol
; 64(1): 41, 2024 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38773538
11.
Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus.
Rheumatology (Oxford)
; 52(12): 2187-95, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23970541
12.
The Role of Autoantibody Testing in Modern Personalized Medicine.
Clin Rev Allergy Immunol
; 63(2): 251-288, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35244870
13.
Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry.
Adv Rheumatol
; 62(1): 13, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35505408
14.
Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force.
Adv Rheumatol
; 62(1): 3, 2022 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039077
15.
COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data.
Adv Rheumatol
; 62(1): 45, 2022 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36419163
16.
Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students' Educational Routines and Mental Health: Protocol for a Web-Based Survey Study.
JMIR Res Protoc
; 10(4): e24617, 2021 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33735094
17.
Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.
Adv Rheumatol
; 61(1): 60, 2021 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34620246
18.
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.
RMD Open
; 7(1)2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33510041
19.
A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study.
JMIR Res Protoc
; 9(12): e24357, 2020 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33156812
20.
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.
Adv Rheumatol
; 60(1): 32, 2020 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32517786